TickerFactsScreenerDevelopers

Estrella Immunopharma, Inc. (ESLAW) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2021: -$316.2K2022: -$1.04M2023: -$1.34M2024: -$16.07M2025: -$1.79M-$1.79M
2021Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$1.79M+88.9%
2024-$16.07M-1102.6%
2023-$1.34M-28.0%
2022-$1.04M-230.2%
2021-$316.2K—